Skip to content

Fear of Hypoglycemia and Glycemic Variability

Peur De l'Hypoglycémie et Variabilité Glycémique Chez Les Sujets Diabétiques de Type 1

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02790060
Acronym
VARDIA
Enrollment
600
Registered
2016-06-03
Start date
2015-06-30
Completion date
Unknown
Last updated
2016-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

diabetes

Brief summary

Subjects with type 1 diabetes are invited to provide usual blood glucose monitoring and a blood glucose profile (Pre/ post prandial Blood Glucose + Night Blood Glucose) on 3 occasions in a 2 week time period, in addition to the filling of 5 questionnaires including fear of hypoglycemia-2 questionnaire.

Detailed description

Subjects with type 1 diabetes are invited to provide usual blood glucose monitoring and a blood glucose profile (Pre/ post prandial Blood Glucose + Night Blood Glucose) on 3 occasions in a 2 week time period, in addition to the filling of questionnaires including fear of hypoglycemia-2 questionnaire. Biobanking of urine/blood Collection of key medical informations by investigators Questionnaires : * socio-economic status * Fear of hypoglycemia-2 * Anxiety Depression scale (HAD) * Health survey (SF36, SF12) * Satisfaction to treatment (DHP-18) * Dutch Eating Behavior Questionnaire (DEBQ) * Pittsburgh quality of sleep (PSQI) * Blood Glucose diary

Interventions

None listed

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

: * type 1 diabetes * at least 2 Blood Glucose monitoring daily * on insulin for more than 5 years

Exclusion criteria

: * not stable metabolic condition (infection, steroid therapy) * below 3 months change in insulin treatment * other clinical trial * renal failure (eDFG below 30 ml/min/1.73 m²) * Pregnancy and/or lactation

Design outcomes

Primary

MeasureTime frameDescription
Fear of hypoglycemia score2 weekshypoglycemia questionnaire and hypoglycemia reported by patients

Secondary

MeasureTime frameDescription
quality of lifefrom 2 weeks up to 3 monthsSF12 questionnaire done once at home and sent at least 2 weeks after onsite visit
Standard Deviation (SD) of recorded Home Monitoring of Blood Glucose (HMPG)2 weeksreports of 2 weeks 4 points profil of HMPG and 3 days of 7 points profil of HMPG

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026